A broad coalition of patients, health professionals, researchers and experts in public health underscored that eliminating viral hepatitis will not take place unless people who use drugs have effective access to prevention and treatment services.
A multi-stakeholder consultation in the Mano Region concluded with recommendations aimed at centring development and public health as key drug policy concerns.